Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers

(2013) Sun Jeong Jang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study

(2013) Signy Holmes et al.   Cancer Epidemiology

Noncommunicable Diseases

(2013) David J. Hunter et al.   NEW ENGLAND JOURNAL OF MEDICINE

T-type calcium channel blockers inhibit autophagy and promote apoptosis of malignant melanoma cells

(2013) Arindam Das et al.   Pigment Cell & Melanoma Research

Nifedipine Treatment Reduces Resting Calcium Concentration, Oxidative and Apoptotic Gene Expression, and Improves Muscle Function in Dystrophic mdx Mice

(2013) Francisco Altamirano et al.   PLoS One

Use of Antihypertensive Medications and Breast Cancer Risk Among Women Aged 55 to 74 Years

(2013) Christopher I. Li et al.   JAMA Internal Medicine

Use of antihypertensive medications and breast cancer risk

(2012) Babette S. Saltzman et al.   CANCER CAUSES & CONTROL

Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro

(2012) Dora Moon et al.   JOURNAL OF SURGICAL RESEARCH

Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias

(2010) Karsten Knobloch et al.   JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY

Long-term use of antihypertensive drugs and risk of cancer

(2008) Themistocles L. Assimes et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY